Editorial: Inhibitors of erythropoiesis.
D000622:Aminolevulinic Acid / Q000096:biosynthesis; D000740:Anemia / Q000652:urine; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism; D001854:Bone Marrow Cells; D003864:Depression, Chemical; D004912:Erythrocytes / Q000378:metabolism; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000502:physiology; D004967:Estrogens / Q000494:pharmacology; D005246:Feedback; D005260:Female; D006418:Heme / Q000502:physiology; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D000860:Hypoxia / Q000097:blood; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D007231:Infant, Newborn; D007501:Iron / Q000378:metabolism; D008297:Male; D051379:Mice; D008954:Models, Biological; D009393:Nephritis / Q000097:blood; D011086:Polycythemia / Q000097:blood; D011087:Polycythemia Vera / Q000097:blood; D051381:Rats
D004967:Estrogens; D006454:Hemoglobins; D007074:Immunoglobulin G; D004921:Erythropoietin; D006418:Heme; D000622:Aminolevulinic Acid; D007501:Iron